Shouyao Holdings (Beijing) Co., LTD. (SHA:688197)
35.75
+0.85 (2.44%)
Nov 5, 2026, 4:00 PM EST
SHA:688197 Revenue
Shouyao Holdings (Beijing) Co., LTD. had revenue of 65.23M CNY in the quarter ending September 30, 2026. This brings the company's total for the last twelve months to 99.90M, up 4,563.92% year-over-year. In the year 2025, Shouyao Holdings (Beijing) Co., LTD. had annual revenue of 8.67M with 119.88% growth. That makes Shouyao Holdings (Beijing) Co., LTD. the 35,430th largest company in the world by revenue and 5,117th in China.
Revenue (ttm)
99.90M
Revenue Growth
+4,563.92%
P/S Ratio
53.22
Revenue / Employee
542.95K
Employees
184
Market Cap
5.32B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.67M | 4.73M | 119.88% |
| Dec 31, 2024 | 3.94M | -1.29M | -24.61% |
| Dec 31, 2023 | 5.23M | 3.40M | 186.18% |
| Dec 31, 2022 | 1.83M | -11.21M | -85.98% |
| Dec 31, 2021 | 13.03M | 6.01M | 85.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Youcare Pharmaceutical Group | 2.36B |
| ChemPartner PharmaTech | 1.27B |
| Shenzhen Weiguang Biological Products | 1.13B |
| Boji Medical Technology | 1.02B |
| R&G PharmaStudies | 957.42M |
| Wuhan Keqian Biology Co.,Ltd | 786.77M |
| Zhejiang Ausun Pharmaceutical | 757.05M |
| PharmaResources (Shanghai) | 724.75M |